Physician

Lindsay Erin Bromley, MD

According to 2025 Medicare claims, Lindsay Bromley, MD (NPI: 1659536126) practices endocrinology in the Oshkosh-Neenah, WI market, with the plurality of this provider's patient population coming from Winnebago, WI. This provider's primary affiliated billing organization is AURORA MEDICAL GROUP, INC. (NPI: 1427271378; TIN: 391678306) and primary practice location at 54904-7668. Bromley is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), THEDACARE ACO (ACO ID: A4988), and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Bromley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 137 traditional Medicare patients, billed 2,701 HCPCS/CPT codes, and received $73,900 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,276 prescription claims across 179 beneficiaries totaling $552,596 in drug costs, led by Ozempic (Semaglutide). DME data shows 41 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $64,915 and ending at $73,900. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $595,160 and ending at $552,596. In contrast, DME billing represents a smaller volume and rose steadily, from $3,505 to $15,557.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	267	16,464	$64,915
2016	273	17,297	$62,443
2017	234	10,130	$40,048
2018	241	13,232	$67,486
2019	192	2,005	$62,120
2020	199	3,685	$61,201
2021	255	6,042	$102,090
2022	261	5,127	$84,399
2023	154	4,678	$89,058
2024	137	2,701	$73,900

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	259	2,317	$595,160
2016	289	2,597	$763,363
2017	267	2,137	$647,308
2018	267	1,911	$540,459
2019	261	1,287	$357,786
2020	250	1,545	$482,615
2021	384	2,469	$992,921
2022	419	2,629	$1,095,333
2023	239	973	$577,427
2024	179	1,276	$552,596

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	32	104	$2,641
2016	50	171	$3,275
2017	33	155	$4,849
2018	24	93	$2,564
2019	19	57	$3,282
2020	26	81	$9,715
2021	63	328	$64,050
2022	77	384	$65,535
2023	14	107	$18,770
2024	N/R	41	$14,162

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	20	20	$138
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	53	76	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	65	97	$73
J0897	Injection, denosumab, 1 mg	23	2,400	$20
96372	Injection of drug or substance under skin or into muscle	24	41	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	103	5,085	$166,549
Jardiance	Empagliflozin	108	6,004	$116,746
Trulicity	Dulaglutide	28	1,036	$34,416
Mounjaro	Tirzepatide	12	588	$22,517
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	142	8,162	$21,685

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	30	$13,875
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	11	$287

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Lindsay Erin Bromley, MD?

Tedicare shows public-source Medicare data for Lindsay Erin Bromley, MD (NPI 1659536126), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lindsay Erin Bromley, MD have ACO affiliation data?

Lindsay Erin Bromley, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033), THEDACARE ACO (MSSP, ACO ID A4988), and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Lindsay Erin Bromley, MD?

Lindsay Erin Bromley, MD is linked to AURORA MEDICAL GROUP, INC. (billing NPI 1427271378) in the available physician profile data.

Does Lindsay Erin Bromley, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.